Mental and Behavioural Disorders
Conditions
Interventions
Placebo
Probiotic
Sponsors
XEN Laboratoires
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - White-collar employees working in a company in Sousse, Tunisia. - aged 19–65 years at the time of informed consent. - Did not regularly take medications. - Did not have a history of serious illness (e.g., diabetes, liver disease, kidney disease, and heart disease).
Exclusion criteria
Exclusion criteria: - Participants who were under pharmacotherapy or clinical treatment for one or more serious diseases. - Those following a medically prescribed diet or exhibiting extremely unbalanced eating habits. - Individuals at risk of developing an allergy to the tested treatment. - Those receiving treatment for mental disorders (such as depression) and/or sleep disorders, or with a history of such conditions. - Individuals using sleeping medications. - Those who had taken probiotics within one month before the study. - Participants with a history of drug dependence. - Heavy drinkers (equivalent to an ethanol intake of 66 g/day). - Individuals with severe diseases such as brain disorders, malignant tumors, immune diseases, diabetes mellitus, hepatic diseases (including hepatitis), renal diseases, cardiac diseases. or serious metabolic disorders (such as thyroid or adrenal disorders), or with a history of such conditions. - Those with a history of intestinal or brain surgery or intestinal diseases other than hernia, hemorrhoids, or appendicitis. - Pregnant, lactating, or potentially pregnant women. - Those who had participated in another clinical study within three months before providing informed consent or planned to participate in another study during the present trial; individuals with irregular working hours (e.g., night shifts). - Those who might have difficulty completing the required questionnaires. - Subjects who declined to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stress;Depression;Anxiety | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of sleep;quality of life caused by abdominal symptoms | — |
Countries
Tunisia
Contacts
Public ContactOlfa EL MAALEL
Professor
Outcome results
None listed